anti-Cytochrome P450, Family 2, Subfamily A, Polypeptide 13 (CYP2A13) Antibodies

CYP2A13 encodes a member of the cytochrome P450 superfamily of enzymes. Additionally we are shipping CYP2A13 Proteins (3) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
CYP2A13 1553 Q16696
CYP2A13    
CYP2A13    
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-CYP2A13 Antibodies at antibodies-online.com

Showing 10 out of 41 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Cow Rabbit Un-conjugated WB WB Suggested Anti-CYP2A13 Antibody Titration:  5.0ug/ml  Positive Control:  HepG2 cell lysate 100 μL Log in to see 2 to 3 Days
$249.00
Details
Dog Rabbit Un-conjugated IC, IF, IP, IHC, WB Immunofluorescent analysis of Cytochrome P450 2A13 staining in HepG2 cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 °C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue). Immunohistochemical analysis of Cytochrome P450 2A13 staining in human lung cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. 200 μL Log in to see 13 to 14 Days
$487.50
Details
Human Rabbit Un-conjugated ELISA, WB Western blot analysis of extracts from HeLa/293/A549 cells, using Cytochrome P450 2A13 Antibody. The lane on the right is treated with the synthesized peptide. 100 μg Log in to see 2 to 3 Days
$302.50
Details
Human Rabbit Un-conjugated ELISA, IF, IHC, WB 100 μL Log in to see Available
$363.46
Details
Human Rabbit Un-conjugated WB 100 μL Log in to see 11 to 14 Days
$507.83
Details
Human Rabbit Un-conjugated EIA, WB Western blot analysis of CYP2A13 Antibody (C-term) in MDA-MB231 cell line lysates (35ug/lane). CYP2A13 (arrow) was detected using the purified Pab. 0.4 mL Log in to see 6 to 8 Days
$484.00
Details
Human Rabbit Un-conjugated FACS, IHC (p), WB Western blot analysis of CYP2A13 Antibody (C-term) (ABIN652591) in MDA-MB231 cell line lysates (35 µg/lane). CYP2A13 (arrow) was detected using the purified polyclonal antibody. Formalin-fixed and paraffin-embedded human breast carcinoma reacted with HADHA Antibody (C-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. 400 μL Log in to see 10 to 11 Days
$385.00
Details
Human Rabbit Un-conjugated ELISA, ICC, IF, WB Western blot analysis of extracts from HepG2, using Cytochrome P450 2A13 Antibody. Lane 1 was treated with the antigen-specific peptide. ABIN6274644 staining HeLa cells by IF/ICC. The sample were fixed with PFA and permeabilized in 0.1% Triton X-100,then blocked in 10% serum for 45 minutes at 25°C. The primary antibody was diluted at 1/200 and incubated with the sample for 1 hour at 37°C. An Alexa Fluor 594 conjugated goat anti-rabbit IgG (H+L) antibody(Cat.# S0006), diluted at 1/600, was used as secondary antibody. 100 μL Log in to see 11 to 12 Days
$390.77
Details
Human Rabbit Un-conjugated IHC, IHC (p) Immunohistochemistry: CYP2A13 Antibody [NBP2-33467] - pancreas Immunohistochemistry: CYP2A13 Antibody [NBP2-33467] - liver cancer 0.1 mL Log in to see 10 to 13 Days
$494.38
Details
Human Rabbit Un-conjugated IF, IHC (p), WB 0.1 mg Log in to see 6 to 8 Days
$434.50
Details

Top referenced anti-CYP2A13 Antibodies

  1. Human Polyclonal CYP2A13 Primary Antibody for IHC, IHC (p) - ABIN4301745 : Fagerberg, Hallström, Oksvold, Kampf, Djureinovic, Odeberg, Habuka, Tahmasebpoor, Danielsson, Edlund, Asplund, Sjöstedt, Lundberg, Szigyarto, Skogs, Takanen, Berling, Tegel, Mulder, Nilsson, Schwenk et al.: Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. ... in Molecular & cellular proteomics : MCP 2014 (PubMed)

More Antibodies against CYP2A13 Interaction Partners

Human Cytochrome P450, Family 2, Subfamily A, Polypeptide 13 (CYP2A13) interaction partners

  1. Oxidation of 1-chloropyrene by human CYP1 family and CYP2A subfamily cytochrome P450 enzymes: catalytic roles of two CYP1B1 and five CYP2A13 allelic variants

  2. CYP2A13 is the most efficient enzyme to metabolize N'-Nitrosonornicotine in vitro.

  3. The results of this case-control study suggested that the CYP2A13*1/*2 genotype decreased the risk of susceptibility to bladder cancer in Japanese smokers

  4. CYP2A13 levels in human lungs can be suppressed by disease-associated inflammation in tissue donors.

  5. an etiologically relevant interaction between CYP2A13 and ABCB1 associated with lung cancer was analysed

  6. The transgenic CYP2A13 is active.

  7. CYP2A13 played a critical role in AFB1-induced neoplastic transformation.

  8. Data suggest important role of CYP2A13 in AFG1- (aflatoxin G1)-induced cytotoxicity, DNA damage, and activation of signal pathways in bronchial epithelium; data suggest similarities in CYP2A13-catalyzed bioactivation of AFG1 and AFB1 (aflatoxin B1).

  9. CYP2A13 is efficient in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation in vivo and it can mediate 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis.

  10. Findings suggest the potential involvement of pulmonary CYP2A13 in the early occurrence of NSCLC as well as in the development of EGFR gene mutations.

  11. an efficient approach for expressing functionally characterized, highly active and homogeneous CYP2A13 proteins.

  12. CYP2A13 plays an important role in low-concentration AFB1-induced DNA damage, possibly linking environmental airborne AFB1 to genetic injury in the human respiratory system.

  13. Findings suggest that CYP2A13 plays an important role in low-concentration AFB1-induced DNA damage, possibly linking environmental airborne AFB1 to genetic injury in human respiratory system.

  14. The differential distribution pattern of CYP2A13 in the respiratory tract, which is of importance in considering the pulmonary susceptibility to carcinogens and the following lung cancer development, is detailed.

  15. Tissue distribution of transgenic mRNA expression agrees well with the known respiratory tract-selective expression of CYP2A13 and CYP2F1 and hepatic expression of CYP2B6 in humans.

  16. Report selective expression of CYP2A13 in human pancreatic alpha-islet cells.

  17. Report CYP2A-selective inhibitors to accurately distinguish between CYP2A6 and CYP2A13 activity.

  18. Although both the hepatic CYP2A6 and respiratory CYP2A13 enzymes metabolize these compounds, CYP2A13 does so with much higher catalytic efficiency, but the structural basis for this has been unclear

  19. The distribution frequencies of all eight known CYP2A13 missense alleles were examined in a Chinese Han population.

  20. present results provide the first direct in vitro evidence demonstrating the predominant roles of CYP2A13 in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced mutagenesis, possibly via metabolic activation of NNK alpha-hydroxylation

CYP2A13 Antigen Profile

Protein Summary

This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. Although its endogenous substrate has not been determined, it is known to metabolize 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a major nitrosamine specific to tobacco. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q.

Gene names and symbols associated with CYP2A13

  • cytochrome P450 family 2 subfamily A member 13 (CYP2A13) antibody
  • cytochrome P450, family 2, subfamily A, polypeptide 13 (CYP2A13) antibody
  • cytochrome P450 family 2 subfamily A member 13 L homeolog (cyp2a13.L) antibody
  • cytochrome P450 family 2 subfamily A member 13 (cyp2a13) antibody
  • cytochrome P450 family 2 subfamily A polypeptide 13 (CYP2A13) antibody
  • cytochrome P450 2A13 (LOC540707) antibody
  • CPAD antibody
  • CYP2A antibody
  • CYP2A6 antibody
  • CYP2A13 antibody
  • CYPIIA13 antibody
  • MGC86391 antibody
  • MGC88881 antibody

Protein level used designations for CYP2A13

cytochrome P450 2A13 , cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 13 , cytochrome P450, family 2, subfamily A, polypeptide 13 , cytochrome P450 family 2 subfamily A polypeptide 13 , LOW QUALITY PROTEIN: cytochrome P450 2A13 , cytochrome P450 2A6

GENE ID SPECIES
1553 Homo sapiens
100064882 Equus caballus
447272 Xenopus laevis
448207 Xenopus (Silurana) tropicalis
484494 Canis lupus familiaris
540707 Bos taurus
Selected quality suppliers for anti-CYP2A13 (CYP2A13) Antibodies
Did you look for something else?